07:00 , Jun 14, 2012 |  BC Innovations  |  Distillery Therapeutics

Indication: Endocrine/metabolic disease

Indication Target/marker/pathway Summary Licensing status Publication and contact information Endocrine/metabolic disease Diabetes Apolipoprotein A-IV (APOA4) Mouse studies suggest APOA4 could help treat type 2 diabetes. In mice fed a high-fat diet, Apoa4 deficiency lowered insulin...